Correlation Between VentriPoint Diagnostics and Manhattan Scients
Can any of the company-specific risk be diversified away by investing in both VentriPoint Diagnostics and Manhattan Scients at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VentriPoint Diagnostics and Manhattan Scients into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VentriPoint Diagnostics and Manhattan Scients, you can compare the effects of market volatilities on VentriPoint Diagnostics and Manhattan Scients and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VentriPoint Diagnostics with a short position of Manhattan Scients. Check out your portfolio center. Please also check ongoing floating volatility patterns of VentriPoint Diagnostics and Manhattan Scients.
Diversification Opportunities for VentriPoint Diagnostics and Manhattan Scients
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between VentriPoint and Manhattan is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding VentriPoint Diagnostics and Manhattan Scients in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Manhattan Scients and VentriPoint Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VentriPoint Diagnostics are associated (or correlated) with Manhattan Scients. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Manhattan Scients has no effect on the direction of VentriPoint Diagnostics i.e., VentriPoint Diagnostics and Manhattan Scients go up and down completely randomly.
Pair Corralation between VentriPoint Diagnostics and Manhattan Scients
Assuming the 90 days horizon VentriPoint Diagnostics is expected to under-perform the Manhattan Scients. But the pink sheet apears to be less risky and, when comparing its historical volatility, VentriPoint Diagnostics is 2.43 times less risky than Manhattan Scients. The pink sheet trades about -0.02 of its potential returns per unit of risk. The Manhattan Scients is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 0.42 in Manhattan Scients on November 4, 2024 and sell it today you would lose (0.41) from holding Manhattan Scients or give up 97.62% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
VentriPoint Diagnostics vs. Manhattan Scients
Performance |
| Timeline |
| VentriPoint Diagnostics |
| Manhattan Scients |
VentriPoint Diagnostics and Manhattan Scients Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with VentriPoint Diagnostics and Manhattan Scients
The main advantage of trading using opposite VentriPoint Diagnostics and Manhattan Scients positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VentriPoint Diagnostics position performs unexpectedly, Manhattan Scients can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Manhattan Scients will offset losses from the drop in Manhattan Scients' long position.| VentriPoint Diagnostics vs. Manhattan Scients | VentriPoint Diagnostics vs. Cannabix Technologies | VentriPoint Diagnostics vs. Accelerate Diagnostics | VentriPoint Diagnostics vs. Venus Concept |
| Manhattan Scients vs. VentriPoint Diagnostics | Manhattan Scients vs. Cannabix Technologies | Manhattan Scients vs. Accelerate Diagnostics | Manhattan Scients vs. Venus Concept |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |